angina pectoris

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from multiple authoritative sources. Let me synthesize a thorough response.

Angina Pectoris

Definition

Angina pectoris is intermittent chest discomfort or pain caused by transient, reversible myocardial ischemia that is insufficient to cause myocyte necrosis. It results from the ischemia-induced release of adenosine, bradykinin, and other molecules that stimulate autonomic afferent nerves. — Robbins & Kumar Basic Pathology

Epidemiology

Nearly 10 million Americans have angina pectoris. Males constitute ~70% of all patients, and an even greater proportion of those aged <50 years. Among adults aged 60–79, ~25% of men and 16% of women have coronary heart disease. Angina is the most frequent clinical expression of myocardial ischemia. — Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine

Pathophysiology

Ischemia rapidly develops when a mismatch arises between myocardial oxygen demand and myocardial oxygen supply. The most common underlying cause is obstructive coronary atherosclerosis. Alternative mechanisms include:
  • Microvascular dysfunction (angina with no obstructive CAD)
  • Vasoconstriction at the site of a dynamic stenosis
  • Mural thrombosis
  • Noncardiac conditions that increase demand or reduce supply (severe anemia, aortic stenosis, hypertrophic cardiomyopathy)
Goldman-Cecil Medicine

Types

1. Stable (Typical) Angina

Predictable, episodic chest discomfort associated with exertion or increased demand (tachycardia). The discomfort is described as a crushing or squeezing substernal sensation, radiating down the left arm or to the jaw. Relieved by rest or nitroglycerin within minutes. — Robbins

2. Prinzmetal (Variant) Angina

Occurs at rest, caused by coronary artery spasm. Can affect atherosclerotic or even otherwise healthy vessels. Responds promptly to vasodilators (nitroglycerin, calcium channel blockers). — Robbins

3. Unstable Angina

Increasingly frequent pain precipitated by progressively less exertion or occurring at rest. Associated with plaque disruption, superimposed thrombosis, distal embolization, and/or vasospasm. Majority of cases show evidence of myocyte injury — treated aggressively to limit irreversible damage. — Robbins

Clinical Presentation (History)

The typical patient is a man >50 years or a woman >60 years. Key features:
  • Quality: Heaviness, pressure, squeezing, smothering, or choking — rarely described as frank "pain"
  • Location: Central, substernal; patient often places a clenched fist over the sternum (Levine's sign)
  • Radiation: Shoulders, both arms (especially ulnar aspects), back, interscapular region, neck, jaw, teeth, epigastrium
  • Duration: Typically 2–5 minutes, crescendo-decrescendo pattern
  • Precipitants: Exertion, emotional stress, cold exposure, heavy meals, sexual activity
  • Relief: Rest, nitroglycerin
  • Angina decubitus: Can occur at rest or when recumbent — may reflect nocturnal tachycardia or increased intrathoracic blood volume during sleep
Myocardial ischemic discomfort does NOT radiate to the trapezius muscles — that pattern is more typical of pericarditis. Angina is rarely localized below the umbilicus or above the mandible.
Harrison's Principles of Internal Medicine 22E

Grading — Canadian Cardiovascular Society (CCS) Scale

ClassDescription
IAngina only with strenuous or prolonged exertion
IISlight limitation of ordinary activity
IIIMarked limitation of ordinary activity
IVInability to perform any activity without angina, or angina at rest
Classes I–II = stable; Classes III–IV = severe/unstable. — Goldman-Cecil Medicine

Investigations

  • Resting ECG: May show ST-segment depression, T-wave changes, or evidence of prior MI
  • Stress testing (exercise ECG, nuclear imaging, stress echo): To provoke and detect ischemia
  • Coronary CT angiography / coronary artery calcium (CAC) score: Adjunctive evidence of atherosclerosis
  • Lab work: CBC, fasting lipid profile, fasting glucose/HbA1c, thyroid function, renal function
  • Coronary angiography: Gold standard for defining anatomy; guides revascularization decisions
  • Echocardiography: Assesses LV function and wall motion

Management

General Approach

  1. Explain the condition and reassure the patient
  2. Identify and treat aggravating conditions (anemia, hypertension, hyperthyroidism, obesity, aortic stenosis)
  3. Adapt activity — reduce speed/intensity, understand diurnal variation in ischemic threshold
  4. Address cardiovascular risk factors (smoking, dyslipidemia, diabetes, hypertension)
  5. Drug therapy
  6. Consider revascularization (PCI or CABG)

Pharmacotherapy

Drug ClassExamplesMechanismRole
NitratesNitroglycerin, isosorbide dinitrate/mononitrateRelease NO → ↑cGMP → vasodilation; ↓venous return, ↓cardiac workSL NTG for acute episodes; oral/transdermal for prophylaxis
Beta-blockersPropranolol, metoprolol, atenololBlock β-adrenoceptors → ↓HR, ↓CO, ↓BP → ↓O₂ demandFirst-line prophylaxis
Calcium channel blockersVerapamil, diltiazem (non-DHP); nifedipine, amlodipine (DHP)Block L-type Ca²⁺ channels → ↓vascular resistance and/or ↓cardiac workVariant angina (especially); stable angina when beta-blockers are contraindicated
AntiplateletAspirin, clopidogrelInhibit platelet aggregationReduce thrombotic events
StatinsAtorvastatin, rosuvastatin↓LDL cholesterol, plaque stabilizationReduce CV events, mandatory in IHD
RanolazineRanolazineInhibits late sodium current → ↓intracellular Ca²⁺ overloadRefractory angina, adjunctive therapy
Key interaction: Nitrates + phosphodiesterase type-5 inhibitors (sildenafil, tadalafil) → synergistic severe hypotension — combination is contraindicated. — Katzung's Basic and Clinical Pharmacology 16E

Revascularization

  • Percutaneous coronary intervention (PCI): For focal lesions, especially in single- or two-vessel disease
  • Coronary artery bypass grafting (CABG): Preferred in left main disease, three-vessel disease, or with LV dysfunction

Prognosis

Prognosis is influenced by:
  • Severity of LV dysfunction (ejection fraction)
  • Number of coronary vessels with significant obstruction
  • Extent of viable but jeopardized myocardium
  • Presence of risk factors (age >75, hypertension, diabetes, dyslipidemia, obesity, peripheral vascular disease, prior MI)
  • Elevated CRP, extensive coronary calcification on CT, carotid intimal thickening — all indicate higher risk
Harrison's Principles of Internal Medicine 22E

Sources: Robbins & Kumar Basic Pathology | Harrison's Principles of Internal Medicine 22E | Goldman-Cecil Medicine | Katzung's Basic and Clinical Pharmacology 16E
This is a shared conversation. Sign in to Orris to start your own chat.